Wellgistics Health revenue was $23.34M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $1.7M, down 44.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, WGRX annual revenue was $23.3M, with 28.7% growth year-over-year.
WGRX past revenue growth
How has WGRX's revenue growth performed historically?
Wellgistics Health (NASDAQ: WGRX) reported Q4 2025 revenue of $1.67 million up 86.54% year over year. In the same quarter last year, Wellgistics Health's revenue was $12.41 million.
What was Wellgistics Health's revenue in 2025?
Wellgistics Health's annual revenue for the twelve months ending Dec 31, 2025 was $23.34 million, a 28.73% increase year over year.
How much does Wellgistics Health make in a day?
Based on Wellgistics Health annual revenue for the past three years, WGRX makes an average of $68,173.00 per day.
What was Wellgistics Health's annual revenue growth in the past year?
As of Q2 2026, Wellgistics Health's revenue has grown 28.73% year over year. This is 13.26 percentage points higher than the US Pharmaceutical Retailers industry revenue growth rate of 15.47%. Wellgistics Health's revenue in the past year totaled $23.34 million.
How much does Wellgistics Health make in a year?
Wellgistics Health's revenue by year for the past three years is:
Wellgistics Health's revenue for the twelve months ending Dec 31, 2025 was $23.34 million, a 28.73% increase year over year.
Wellgistics Health's annual revenue for Dec 31, 2024 was $18.13 million, a 45.37% decrease from 2023.
Wellgistics Health's annual revenue for 2023 was $33.18 million, a 4.06% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.